PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
28-Feb-2020 MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020 MR Solutions’
28-Feb-2020 Kiadis Pharma announces FDA clearance of clinical study by The Ohio State University in R/R AML with off-the-shelf NK cells from universal donors Kiadis
26-Feb-2020 Time To Start Trading | Register With The Experts Now‎ Global Trade Investment Solutions Global Trade Investment Solutions
25-Feb-2020 TrakCel and Ori Biotech sign a collaboration agreement for supply chain orchestration within cell and gene therapy manufacturing TrakCel
25-Feb-2020 ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services ImmunOs Therapeutics
25-Feb-2020 Novo Seeds Portfolio Company IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Trial in First Line Non-small Cell Lung Cancer Novo Holdings A/S
25-Feb-2020 Akili Announces Publication of AKL-T01 ADHD Pivotal Study Results in The Lancet Digital Health Akili
25-Feb-2020 Chi-Med to announce 2019 Final Results on Tuesday, March 3, 2020 – adjustment to announcement and presentation logistics due to travel restrictions Chi-Med
25-Feb-2020 OMass Announces Acquisition of Pharmacology Capabilities from Excellerate Biosciences OMass Therapeutics
25-Feb-2020 Nuance Announces the General Availability of Ambient Clinical Intelligence Nuance Communications, Inc.
25-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Almirall and Paratek enter into a License Agreement for Seysara® in China Almirall
24-Feb-2020 Positive long-term data in retinal clinical trial ReNeuron Group plc
24-Feb-2020 ASLAN PHARMACEUTICALS TO PRESENT AT 9th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE ASLAN Pharmaceuticals
24-Feb-2020 FDA approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine H. Lundbeck A/S
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
24-Feb-2020 Genmab Board of Directors Chairman to Step Down Genmab
24-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd
21-Feb-2020 Exclusive interview with Pharma Microbiology Boston Conference Chair Lynne Ensor, speaks about Coronavirus SMi Group